A five-factor biomarker profile obtained week 4–12 of treatment for improved prognostication in metastatic renal cell carcinoma: Results from DARENCA study 2
Soerensen, A. V., Geertsen, P. F., Christensen, I. J., Hermann, G. G., Jensen, N. V., Fode, K., Petersen, A., Sandin, R. & Donskov, F., 2016, I: Acta Oncologica.55, 3, s. 341-3488 s.